2023年

  1. Hisashi Ishida, Toshihiko Imamura, Yasuhisa Tatebe, Takashi Ishihara, Kimiyoshi Sakaguchi, Souichi Suenobu, Atsushi Sato, Yoshiko Hashii, Takao Deguchi, Yoshihiro Takahashi, Daiichiro Hasegawa, Takako Miyamura, Akihiro Iguchi, Koji Kato, Akiko Saito-Moriya, Junichi Hara, and Keizo Horibe.
    Impact of asparaginase discontinuation on outcomes of children with acute lymphoblastic leukemia receiving the Japan Association of Childhood Leukemia Study ALL-02 protocol.
    British Journal of Haematology. In press.

2022年

  1. Kenta Yagi, Akinori Maruo, Shunsuke Ishida, Fuka Aizawa, Soichiro Ushio, Satoshi Sakaguchi, Makoto Kajizono, Takahiro Niimura, Mitsuhiro Goda, Hirofumi Hamano, Yuki Izawa-Ishizawa, Yoshito Zamami, Keisuke Ishizawa. Effects of Vonoprazan and Proton Pump Inhibitors on the Efficacy of Bevacizumab: A Multicentre Retrospective Study.Clinical and Experimental Medicine. In press.
  2. Mitsuboshi Satoru, Hamano Hirofumi, Kuniki Yurika, Niimura Takahiro, Chuma Masayuki, Ushio Soichiro, LIN Tsung-Jen, Matsumoto Jun, Takeda Tatsuaki, Kajizono Makoto, Zamami Yoshito, Ishizawa Keisuke. Proton pump inhibitors and rhabdomyolysis: analysis of two different cross-sectional databases. The Annals of Pharmacotherapy. In press.
  3. Tamefusa K, Ishida H, Kanamitsu K, Ochi M, Fujiwara K, Tatebe Y, Aoe M, Nodomi S, Washio K. Posttransplant gilteritinib maintenance therapy for pediatric acute myeloid leukemia with myelodysplasia-related changes with FLT3-internal tandem duplication.
    Pediatr Blood Cancer. 2022: e30108. Online ahead of print.
  4. Matsumoto J, Nishimoto A, Watari S, Ueki H, Shiromizu S, Iwata N, Takeda T, Ushio S, Kajizono M, Fujiyoshi M, Koyama T, Araki M, Wada K, Zamami Y, Nasu Y, Ariyoshi N. Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expression in the clinical outcome of renal cell carcinoma. Mol Cell Biochem. In press.
  5. Niimura T, Zamami Y, Miyata K, Mikami T, Asada M, Fukushima K, Yoshino M, Mitsuboshi S, Okada N, Hamano H, Sakurada T, Matsuoka-Ando R, Aizawa F, Yagi K, Goda M, Chuma M, Koyama T, Izawa-Ishizawa Y, Yanagawa H, Fujino H, Yamanishi Y, Ishizawa K. Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the United States Food and Drug Administration Adverse Event Reporting System. J Clin Pharmacol. 2022; Online ahead of print.
  6. Esumi S, Ushio S, Zamami Y. Polypharmacy in Older Adults with Alzheimer's Disease. Medicina (Kaunas). 2022; 58(10):1445. Review.
  7. Chuma M, Hamano H, Bando T, Kondo M, Okada N, Izumi Y, Ishida S, Yoshioka T, Asada M, Niimura T, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Kasamo S, Izawa-Ishizawa Y, Azuma M, Yanagawa H, Tasaki Y, Ishizawa K. Non-recovery of vancomycin-associated nephrotoxicity is related to worsening survival outcomes: Combined retrospective analyses of two real-world databases. Basic Clin Pharmacol Toxicol. 2022;131(6):525-535.
  8. Nawa H, Hamano H, Niimura T, Miyata K, Yagi K, Goda M, Zamami Y, Ishizawa K. Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects. Clin Transl Sci. 2022; Online ahead of print.
  9. Yasuhisa Tatebe, Soichiro Ushio, Satoru Esumi, Hikaru Sada, Motoharu Ochi, Kosuke Tamefusa, Hisashi Ishida, Kaori Fujiwara, Kiichiro Kanamitsu, Kana Washio, Risa Katsube, Kiminaka Murakawa, Yoshito Zamami. Low-dose acyclovir for prophylaxis of varicella-zoster virus reactivation after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer. 2022; 69(12):e29979.
  10. Koyama T, Higashionna T, Maruo A, Ushio S, Zamami Y, Harada K, Hagiya H. Trends in places and causes of death among centenarians in Japan from 2006 to 2016. Geriatr Gerontol Int. 2022; 22(8):675-680.
  11. Ochi K, Suzawa K, Thu YM, Takatsu F, Tsudaka S, Zhu Y, Nakata K, Takeda T, Shien K, Yamamoto H, Okazaki M, Sugimoto S, Shien T, Okamoto Y, Tomida S, Toyooka S.
    Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer-associated fibroblast. Cancer Sci. 2022; Online ahead of print.
  12. Matsumoto J, Iwata N, Watari S, Ushio S, Shiromizu S, Takeda T, Hamano H, Kajizono M, Araki M, Nasu Y, Ariyoshi N, Zamami Y..　Adverse Events of Axitinib plus Pembrolizumab versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in FDA Adverse Event Reporting System. European Urology Focus. 2022; S2405-4569(22)00164-X.
  13. Nishiuchi S, Yagi K, Saito H, Zamami Y, Niimura T, Miyata K, Sakamoto Y, Fukunaga K, Ishida S, Hamano H, Aizawa F, Goda M, Chuma M, Izawa-Ishizawa Y, Nawa H, Yanagawa H, Kanda Y, Ishizawa K.　Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis.　European Journal of Pharmacology. . 2022 Aug;928:175083.
  14. Higashionna T, Ushio S, Esumi S, Murakawa K, Kitamura Y, Sendo T Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating febrile Neutropenia during Chemotherapy in Patients with Lung Cancer Acta Med Okayama. 2022 Apr;76(2):167-172.
  15. Fujimori T, Hagiya H, Iio K, Higashionna T, Kakehi A, Okura M, Minabe H, Yokoyama Y, Otsuka F, Higashikage A. Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan J Infect Chemother. 2022 Mar 26;S1341-321X(22)00096-4.
  16. Takahashi M, Hagiya H, Higashionna T, Nakano Y, Sato K, Haruki Y, Haruki M, Honda H, Ogawa H, Ueda K, Otsuka F Antimicrobial Prescription Practices for Outpatients with Uncomplicated Cystitis in Japan Sci Rep. 2022 Apr 8;12(1):5921.
  17. Kenta Yagi, Yasutaka Sato, Satoshi Sakaguchi, Mitsuhiro Goda, Hirofumi Hamano, Fuka Aizawa, Mayuko Shimizu, Arisa Inoue-Hamano, Toshihide Nishimori, Masato Tagi, Marina Kanno, Rie Matsuoka-Ando, Toshihiko Yoshioka, Yoshiko Matstubara, Yuki Izawa-Ishizawa, Rieko Shimizu, Akinori Maruo, Yurika Kuniki, Yoshika Sakamoto, Sayuri Itobayashi, Yoshito Zamami, Hiroaki Yanagawa, Keisuke Ishizawa. A web-based survey of educational opportunities of medical professionals based on changes in conference design during the COVID-19 pandemic. Education and Information Technologies, 2022 Apr 18;1-16.
  18. Masaya Kanda, Mitsuhiro Goda, Akiko Maegawa, Toshihiko Yoshioka, Ami Yoshida, Koji Miyata, Fuka Aizawa, Takahiro Niimura, Hirofumi Hamano, Naoto Okada, Takumi Sakurada, Masayuki Chuma, Kenta Yagi, Yuki Izawa-Ishizawa, Hiroaki Yanagawa, Yoshito Zamami, Keisuke Ishizawa. Discovery of preventive drugs for cisplatin-induced acute kidney injury using big data analysis. Transl. Sci., 2022 Apr 20.
  19. Yasutaka Sato, Satoshi Sakaguchi, Kenshi Takechi, Masayuki Chuma, Kenta Yagi, Chikako Kane, Mitsuhiro Goda, Hirofumi Hamano, Yuki Aoe, Hiroshi Nokihara, Yoshiaki Kubo, Ichiro Hashimoto, Hiroaki Yanagawa. Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan Pharma. Bull, 2022; 45(3): 374-377.
  20. Zamami Y, Niimura T, Kawashiri T, Goda M, Naito Y, Fukushima K, Ushio S, Aizawa F, Hamano H, Okada N, Yagi K, Miyata K, Takechi K, Chuma M, Koyama T, Kobayashi D, Shimazoe T, Fujino H, Izawa-Ishizawa Y, Ishizawa K. Identification of prophylactic drugs for oxaliplatin-induced peripheral neuropathy using big data. Biomed Pharmacother. 2022 Apr;148:112744.
  21. Mitsuboshi S, Niimura T, Yoshino M, Sakamoto Y, Zamami Y, Ishizawa K. Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database: Int J Clin Pharm. 2022 Feb;44(1):260-263.
  22. Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Tasaki Y, Ishizawa K. Association between statin use and daptomycin-related musculoskeletal adverse events: A mixed approach combining a meta-analysis and a disproportionality analysis. Clinical Infectious Diseases, 2022 Mar.
  23. Mitsuboshi S, Niimura T, Aizawa F, Goda M, Zamami Y, Ishizawa K. Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database. Basic Clin Pharmacol Toxicol. 2022 Feb 16.
  24. Uchida M, Ushio S, Niimura T, Takechi K, Kawazoe H, Hidaka N, Tanaka A, Araki H, Zamami Y, Ishizawa K, Kitamura Y, Sendou T, Kawasaki H, Namba H, Shibata K, Tanaka M, Takatori S. Renin-Angiotensin-Aldosterone System Inhibitors Prevent the Onset of Oxaliplatin-Induced Peripheral Neuropathy: A Retrospective Multicenter Study and in Vitro Evaluation. Biol Pharm Bull. 2022 Feb 1;45(2):226-234.
  25. Sakurada T, Nokihara H, Koga T, Zamami Y, Goda M, Yagi K, Hamano H, Aizawa F, Ogino H, Sato S, Kirino Y, Goto H, Nishioka Y, Ishizawa K. Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study. The Oncologist, 2022 Mar 24. 2021年
2021年
  1. Honda H, Hagiya H, Higashionna T, Haruki Y, Haruki M, Kajita S, Mukuda K, Yokoyama Y, Nakano Y, Ogawa H, Morimoto Y, Hanayama Y, Kanda S, Kataoka H, Muguruma H, Otsuka F.: Impact of the day of the week on the discontinuation of broad-spectrum antibiotic prescriptions; a multi-centered observational study. Sci Rep. 11(1):20784, 2021.
  2. Tsukahara H, Higashionna T, Tsuge M, Miyamura J, Kusano N.: Coronavirus disease 2019 in Okayama Prefecture: Looking back and looking forward. Glob Health Med. 3(2):102-106, 2021.
  3. Fujihara M, Shien T, Shien K, Suzawa K, Takeda T, Zhu Y, Mamori T, Otani Y, Yoshioka R, Uno M, Suzuki Y, Abe Y, Hatono M, Tsukioki T, Takahashi Y, Kochi M, Iwamoto T, Taira N, Doihara H, Toyooka S.: YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development. Int J Mol Sci. 22(23):12809, 2021.
  4. Tabuchi H, Kitamura Y, Ushio S, Kan S, Wada Y, Sumiyoshi Y, Izushi Y, Miyazaki I, Asanuma M, Sendo T.:Influence of 5-HT2A receptor function on anxiety-like behavior induced by a combination treatment with doxorubicin and cyclophosphamide in rats. Psychopharmacology (Berl). 238(12): 3607-3614, 2021. doi: 10.1007/s00213-021-05979-5.
  5. Kataoka Y, Anan K, Taito S, Tsujimoto Y, Kurata Y, Wada Y, Maruta M, Kanaoka K, Oide S, Takahashi S, Nango E.:Quality of clinical practice guidelines in Japan remains low: a cross-sectional meta-epidemiological study.J Clin Epidemiol. 2021 Jul 2;138:22-31. doi: 10.1016/j.jclinepi.2021.06.025
  6. Morio K, Kurata Y, Kawaguchi-Sakita N, Shiroshita A, Kataoka Y.:Efficacy of Metformin in Patients With Breast Cancer Receiving Chemotherapy or Endocrine Therapy: Systematic Review and Meta-analysis. Ann Pharmacother. June 17, 2021. doi: 10.1177/10600280211025792.
  7. Matsumoto D, Ushio S, Wada Y, Noda Y, Esumi S, Izushi Y, Kitamura Y, Sendo T.:Bumetanide prevents diazepam-modified anxiety-like behavior in lipopolysaccharide-treated mice. Eur. J. Pharmacol. 2021 Aug 5;904:174195
  8. Kishi T, Sakuma K, Okuya M, Matsuda Y, Esumi S, Hashimoto Y, Hatano M, Miyake N, Miura I, Mishima K, Iwata N.: Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized, placebo-controlled trials. Bipolar Disord. 2021 Feb 9. doi: 10.1111/bdi.13053. (Online ahead of print.)
  9. Tsukahara H, Higashionna T, Tsuge M, Miyamura J, Kusano N.COVID-19 in Okayama Prefecture: Looking back and looking forward. Glob Health Med. 2021; 3(2):102-106.
2020年
  1. Tatebe Y, Kanamitsu Y, Kanzaki H, Ishida H, Fujiwara K, Washio K, Kitamura Y, Sendo T, Shimada A, Tsukahara H.: Delayed Methotrexate Elimination after Administration of a Medium Dose of Methotrexate in a Patient with Genetic Variants Associated with Methotrexate Clearance. Acta Medica Okayama 74: 545-550, 2020.
  2. Kikuoka R, Miyazaki I, Kubota N, Maeda M, Kagawa D, Moriyama M, Sato A, Murakami S, Kitamura Y, Sendo T, Asanuma M.: Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection. Scientific Reports. Nov 26;10(1):20698. doi: 10.1038/s41598-020-77652-4.
  3. Kitamura Y, Ushio S, Sumiyoshi Y, Wada Y, Miyazaki I, Asanuma M, Sendo T.: N-acetylcysteine attenuates the anxiety-like behavior and spatial cognition impairment induced by doxorubicin and cyclophosphamide combination treatment in rats. Pharmacology. 2020 Dec 22;1-8. doi: 10.1159/000512117.
  4. Gomita Y, Esumi S, Ushio S, Kitamura Y, Sendo T, Motoda H, Inoue S, Araki H, Kano Y.: Intracranial self-stimulation-reward or immobilization-aversion had different effects on neurite extension and the ERK pathway in neurotransmitter-sensitive mutant PC12 cells. Behav Brain Res. 2020 Sep 20. doi: 10.1016/j.bbr.2020.112920.
  5. Kameda S, Kitamura Y, Masaoka Y, Fujimoto M, Ushio S, Sendo T.: Investigation of the difficulties experienced by pharmacists in Japan when communicating with cancer patients. J Clin Pharm Ther. 2020 Sep 25. doi: 10.1111/jcpt.13278
  6. Sada H, Kajizono M, Ushio S, Esumi S, Kitamura Y, Sendo T.: The Efficacy and Safety of Lubiprostone for Constipation in Cancer Patients Compared with Non-cancer Patients: A Retrospective Cohort Study. Biol Pharma Bull. 43: 1699-1706, 2020.
  7. Takahashi K, Kitamura Y, Ushio S, Sendo T.:Immobility-reducing Effects of Ketamine during the Forced Swim Test on 5-HT1A Receptor Activity in the Medial Prefrontal Cortex in an Intractable Depression Model. Acta Medica Okayama 74: 301-306, 2020.
  8. Masaoka Y, Kawasaki Y, Kikuoka R, Ogawa A, Esumi S, Wada Y, Ushio S, Kitamura Y, Sendo T.: Development of an appropriate simple suspension method for valganciclovir medication. Journal of Pharmaceutical Health Care and Sciences. 6, 2020. https://doi.org/10.1186/s40780-020-00172-w
  9. Miyauchi S, Shien K, Takeda T, Araki K, Nakata K, Miura A, Takahashi Y, Kurihara E, Ogoshi Y, Namba K, Suzawa K, Yamamoto H, Okazaki M, Soh J, Tomida S, Yamane M, Sakaguchi M, Toyooka S.: Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation. Anticancer Res . 2020 May;40(5):2667-2673. doi: 10.21873/anticanres.14237.
  10. Koyama T, Hagiya H, Teratani Y, Tatebe Y, Ohshima A, Adachi M, Funahashi T, Zamami Y, Tanaka HY, Tasaka K, Shinomiya K, Kitamura Y, Sendo T, Hinotsu S, Kano MR.: Antibiotic prescriptions for Japanese outpatients with acute respiratory tract infections (2013-2015): A retrospective Observational Study. J Infect Chemother. 26: 660-660, 2020. pii: S1341-321X(20)30042-8. doi: 10.1016/j.jiac.2020.02.001.
  11. Koyama T, Hagiya H, Funahashi T, Zamami Y, Yamagishi M, Onoue H, Teratani Y, Mikami N, Shinomiya K, Kitamura Y, Sendo T, Hinotsu S, Kano MR.: Trends in Place of Death in a Super-Aged Society: A Population-Based Study, 1998-2017. J Palliat Med. 23: 950-956, 2020. doi: 10.1089/jpm.2019.0445.